BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2019
View Archived Issues
New model explains neural basis of alternating bilateral sensory stimulation for fear disorders
Read More
Stress hormones help metastasis along
Read More
How the other half controls appetite
Read More
Clotting protein cuts neuromuscular synapses, if it can
Read More
SunRegen Healthcare presents data on SRG-003 in monkeys with optic atrophy
Read More
Preclinical PK/PD studies help determine first-in-human dose of RG-7827
Read More
JP-1366 demonstrates safety and favorable PK in healthy subjects
Read More
FDA approves sNDA for Avycaz for pediatric patients with cUTI and cIAI
Read More
FDA clears Zenith Epigenetics' IND application for ZEN-3694 in TNBC program
Read More
Idorsia patents antibacterial pyrroloimidazolones
Read More
Novartis patent describes compounds for cancer
Read More
Asceneuron discloses OGA inhibitors
Read More
Sprint Bioscience synthesizes PIK3C3 inhibitors
Read More
TIME-2b study of AKB-9778 in diabetic retinopathy does not meet primary endpoint
Read More
ACADIA Pharmaceuticals presents 5-HT2A receptor ligands
Read More
Pascal Biosciences and Mitacs partner to support cancer research project at UBC
Read More
FDA approves Tecentriq with chemotherapy for first-line treatment of extensive-stage SCLC
Read More
Clinical data reported for litoxetine in mixed urinary incontinence
Read More
First subject dosed in phase II study of GRF-6019 in patients with severe Alzheimer's disease
Read More
Nicox opens phase II trial of NCX-4251 in blepharitis
Read More
NAMPT might predict docetaxel resistance in prostate cancer
Read More
First-in-human results for miltuximab described, theranostic trial of 89Zr/177Lu-miltuximab planned
Read More
Emergent BioSolutions initiates phase III study of anthrax vaccine AV-7909
Read More
Moleculin Biotech enrolls first patients in European trial of WP-1220 for CTCL
Read More
Crinetics initiates phase II program for CRN-00808 in acromegaly
Read More